In the pursuit of precision and performance in life science research, bioconjugation is a critical tool for enabling targeted molecular connections. This webinar, hosted by Vector Laboratories, ...

The epidemiology of known vector-borne pathogens is changing as common vectors move to new locations. Scientists seek novel strategies for mitigating public health risks and healthcare system burdens.

The COVID-19 pandemic is a dramatic reminder of the problems that viral zoonoses can cause worldwide. The rapid development of vaccines and antivirals against SARS-CoV-2 was only possible because the ...

The last time I wrote about 4D Molecular Therapeutics, Inc. (FDMT), it was in a Seeking Alpha article entitled “4d Molecular Therapeutics: Several Value Inflection Points To Watch In 2024.” In this ...

Please provide your email address to receive an email when new articles are posted on . Astellas has gained the rights to utilize 4DMT’s R100 vector to deliver its unique genetic payloads. Astellas is ...